BNY Mellon Select Managers Small Cap Value Fund
- TICKER DMVAX
- Fund Code 6246
- CUSIP 05587K782
- SHARE CLASS
-
Literature Download
Why invest in this Fund?
Morningstar Rating™ as of February 28, 2023 for the Class A class shares; other classes may have different performance characteristics. Overall rating for the Small Blend category. Fund ratings are out of 5 Stars: Overall 3 Stars (585 funds rated); 3 Yrs. 4 Stars (585 funds rated); 5 Yrs. 3 Stars (543 funds rated); 10 Yrs. 3 Stars (367 funds rated). The Morningstar Rating™ for funds, or "star rating", is calculated for managed products with at least a 3-year history. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance (not including the effects of sales charges, loads and redemption fees if applicable), placing more emphasis on downward variations and rewarding consistent performance. Managed products; including open-end mutual funds, closed-end funds and exchange-traded funds; are considered a single population for comparative purposes. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. © Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results. The fund represents a single portfolio with multiple share classes that have different expense structures. Other share classes may have achieved different results.
Portfolio Managers
-
Elena Goncharova, CFA
Lead Portfolio Manager,
4 yr(s). on fund
Total Returns
Month End
Average Annual As of 02/28/23 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 02/28/23 |
YTD 02/28/23 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon Select Managers Small Cap Value Fund
DMVAX |
-3.54 | 1.50 | -11.16 | 11.24 | 5.62 | 8.00 | 10.94 |
Russell 2000® Value Index
|
0.00 | 7.02 | -4.40 | 12.87 | 6.38 | 8.46 | - |
Quarter End
Average Annual As of 12/31/22 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 12/31/22 |
YTD 12/31/22 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon Select Managers Small Cap Value Fund
DMVAX |
3.58 | -21.41 | -21.41 | 4.20 | 3.64 | 7.98 | 10.49 |
Russell 2000® Value Index
|
8.42 | -14.48 | -14.48 | 4.70 | 4.13 | 8.48 | - |
The Russell 2000® Value Index measures the performance of the small-cap value segment of the U.S. equity universe. It includes those Russell 2000 companies that are considered more value-oriented relative to the overall market as defined by Russell’s leading style methodology. The Russell 2000® Value Index is constructed to provide a comprehensive and unbiased barometer for the small-cap value segment. The index is completely reconstituted annually to ensure larger stocks do not distort the performance and characteristics of the true small-cap opportunity set and that the represented companies continue to reflect value characteristics. Investors cannot invest directly in any index.
Growth of $10,000 Investment
Historical Performance
Yearly Total Return
Yearly
Prospectus Fee Table Expense Ratios
As of 03/31/22 Fee Description | Expense Ratio (%) |
---|---|
Management Fee | 0.90% |
Service Fee | 0.25% |
Other Expenses | 0.18% |
Total Expenses | 1.33% |
Expenses Reimbursed | 0.03% |
Net Expenses | 1.30% |
The fund's investment adviser, BNY Mellon Investment Adviser, Inc., has contractually agreed, until March 31, 2023, to waive receipt of its fees and/or assume the direct expenses of the fund so that the direct expenses of none of the fund's classes (excluding Rule 12b-1 fees, shareholder services fees, taxes, interest, brokerage commissions, commitment fees on borrowings and extraordinary expenses) exceed 1.05%. On or after March 31, 2023, BNY Mellon Investment Adviser, Inc. may terminate this expense limitation agreement at any time.
Sales Charge
Portfolio Manager/Sub-Investment Adviser
Asset Allocation
Daily Statistics
As of 03/24/23 Name | NAV | Change |
04/01/22 12 Month High Nav |
09/30/22 12 Month Low Nav |
YTD Return |
---|---|---|---|---|---|
DMVAX
|
$19.78 |
$0.15
0.76%
|
$24.69 | $19.61 | -1.54% |
Performance Metrics
Overall Morningstar Rating
MORNINGSTAR CATEGORY Small Blend
Morningstar Rating™ as of 02/28/23 for the Class A shares; other classes may have different performance
characteristics. Overall rating for the Small Blend. Fund ratings are out of 5 Stars: Overall
3 Stars (585 funds rated); 3 Yrs.
4 Stars (585 funds rated); 5 Yrs.
3 Stars (543 funds rated); 10 Yrs.
3 Stars (367 funds rated).
The
Morningstar Rating™ for funds, or "star rating", is calculated for managed products with at least a 3-year history. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for
variation in a managed product's monthly excess performance (not including the effects of sales charges, loads and redemption fees if applicable), placing more emphasis on downward variations and rewarding
consistent performance. Managed products; including open-end mutual funds, closed-end funds and exchange-traded funds; are considered a single population for comparative purposes. The top 10% of products in
each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a
managed product is derived from a weighted average of the performance figures associated with its 3-, 5-,and 10-year (if applicable) Morningstar Rating metrics. ©
Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be
accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future
results. The fund represents a single portfolio with multiple share classes that have different expense structures. Other share classes may have achieved different results.
Lipper Rankings
-
1 Year
718 out of 908 -
3 Year
441 out of 864 -
5 Year
401 out of 803 -
10 Year
338 out of 563
LIPPER CLASSIFICATION Small-Cap Core Funds
Main Risks
Small and midsized company stocks tend to be more volatile and less liquid than larger company stocks as these companies are less established and have more volatile earnings histories.
Investing in foreign denominated and/or domiciled securities involves special risks, including changes in currency exchange rates, political, economic, and social instability, limited company information, differing auditing and legal standards, and less market liquidity. These risks generally are greater with emerging market countries.
Multi-manager risk means each sub adviser makes investment decisions independently, and it is possible that the investment styles of the sub advisers may not complement one another. Consequently, the fund's exposure to a given stock, industry or investment style could be greater or smaller than if the fund had a singleadviser.
Recent market risks include pandemic risks related to COVID-19. The effects of COVID-19 have contributed to increased volatility in global markets and will likely affect certain countries, companies, industries and market sectors more dramatically than others. To the extent the fund may overweight its investments in certain countries, companies, industries or market sectors, such positions will increase the fund's exposure to risk of loss from adverse developments affecting those countries, companies, industries or sectors.
Risk Metrics
As of 02/28/23 3-Year Trailing | Standard Deviation | Alpha | Beta | R-Squared | Sharpe Ratio |
---|---|---|---|---|---|
DMVAX
|
25.01 | 1.24 | 1.07 | 79.82 | 0.59 |
All risk metrics are provided by Morningstar. The index used in the calculations are determined by Morningstar which may not be the funds primary benchmark. The index Morningstar used for this analysis is S&P 500® Index.
Dividend Schedule
Year | Dividend ($) | Capital Gains ($) |
---|---|---|
2022 | 0.0557 | 1.9086 |
2021 | 0.0000 | 4.2457 |
2020 | 0.0380 | 1.1186 |
2019 | 0.0084 | 0.3889 |
2018 | 0.0006 | 2.6920 |
2017 | 0.0000 | 1.4849 |
2016 | 0.0744 | 0.0202 |
2015 | 0.1139 | 1.2792 |
2014 | 0.0000 | 2.9193 |
2013 | 0.0784 | 2.1364 |
Distributions History
Record Date | Ex-Dividend Date | Payable Date |
Ordinary Non-Qualified Dividends |
Qualified Dividends |
Non-Qualified Short-Term Capital Gain |
Qualified Short-Term Capital Gain |
Long-Term Capital Gain |
Total Distribution |
Reinvest NAV |
---|---|---|---|---|---|---|---|---|---|
12/20/22 | 12/21/22 | 12/21/22 | 0.0000 | 0.0557 | 0.0000 | 0.0000 | 1.4101 | 1.4658 | 20.11 |
Record Date | Ex-Dividend Date | Payable Date |
Ordinary Non-Qualified Dividends |
Qualified Dividends |
Non-Qualified Short-Term Capital Gain |
Qualified Short-Term Capital Gain |
Long-Term Capital Gain |
Total Distribution |
Reinvest NAV |
---|---|---|---|---|---|---|---|---|---|
03/28/22 | 03/29/22 | 03/29/22 | - | 0.0000 | 0.0307 | 0.0000 | 0.4678 | 0.4985 | - |
12/21/21 | 12/22/21 | 12/22/21 | 0.0000 | 0.0000 | 1.2775 | 0.2522 | 2.4587 | 3.9884 | - |
03/26/21 | 03/29/21 | 03/29/21 | - | 0.0000 | - | 0.0000 | 0.2573 | 0.2573 | - |
12/29/20 | 12/30/20 | 12/30/20 | 0.0000 | 0.0380 | 0.0000 | 0.0000 | 1.0741 | 1.1121 | - |
03/23/20 | 03/24/20 | 03/24/20 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0445 | 0.0445 | - |
12/30/19 | 12/31/19 | 12/31/19 | 0.0000 | 0.0084 | 0.0000 | 0.0000 | 0.3889 | 0.3973 | - |
12/28/18 | 12/31/18 | 12/31/18 | 0.0000 | 0.0006 | 0.0256 | 0.2822 | 2.3635 | 2.6719 | - |
03/19/18 | 03/20/18 | 03/20/18 | 0.0000 | 0.0000 | 0.0015 | 0.0000 | 0.0192 | 0.0207 | - |
12/28/17 | 12/29/17 | 12/29/17 | 0.0000 | 0.0000 | 0.0304 | 0.2659 | 1.1886 | 1.4849 | - |
12/29/16 | 12/30/16 | 12/30/16 | 0.0000 | 0.0744 | 0.0000 | 0.0000 | 0.0000 | 0.0744 | - |
03/22/16 | 03/23/16 | 03/23/16 | 0.0000 | 0.0000 | 0.0000 | 0.0037 | 0.0165 | 0.0202 | - |
12/30/15 | 12/31/15 | 12/31/15 | 0.0000 | 0.1095 | 0.0000 | 0.1390 | 1.1368 | 1.3853 | - |
See all rows... |
Literature
Factsheet, Prospectus and Reports
- Download
- Share
- Subscribe
- Order